Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Decibel Therapeutics, Inc. Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update August 11, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference June 02, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting June 01, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit May 17, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update May 15, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics Announces Approval of Clinical Trial Application by the Spanish Agency of Medicines and Medical Devices (AEMPS) to Initiate Clinical Development of Lead Gene Therapy Candidate DB-OTO May 12, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting May 10, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics Receives European Orphan Drug Designation for Lead Gene Therapy Candidate DB-OTO March 30, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics to Participate in the Upcoming Guggenheim Healthcare Talks | Genomic Medicines and Rare Disease Days March 28, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics Appoints Matthew Kapusta to its Board of Directors March 21, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update March 14, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics to Present at the Upcoming SVB Securities Global Biopharma Conference February 16, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics to Present at the 46th Annual Association for Research in Otolaryngology (ARO) MidWinter Meeting February 09, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics Announces Approval of Clinical Trial Application by the U.K. Medicines and Healthcare Products Regulatory Agency for Lead Gene Therapy Candidate DB-OTO January 24, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Update November 09, 2022 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics Announces Submission of Clinical Trial Applications for Lead Gene Therapy Candidate DB-OTO November 02, 2022 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics Receives FDA Clearance of IND Application for DB-OTO, a Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin-Related Hearing Loss October 17, 2022 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Decibel Therapeutics Appoints Kevin F. McLaughlin to its Board of Directors October 12, 2022 From Decibel Therapeutics, Inc. Via GlobeNewswire Tickers DBTX Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
